AF
WST icon

Avanza Fonder’s West Pharmaceutical WST Stock Holding History

Avanza Fonder’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Sell
5,992
-1,516
-20% -$463K 0.05% 273
2026
Q1 		$1.88M Hold
7,508
– – 0.05% 276
2025
Q4 		$2.07M Hold
7,508
– – 0.05% 267
2025
Q3 		$1.97M Hold
7,508
– – 0.05% 256
2025
Q2 		$1.64M Hold
7,508
– – 0.05% 280
2025
Q1 		$1.66M Sell
7,508
-285
-4% -$78.5K 0.05% 274
2024
Q4 		$2.55M Buy
+7,793
New +$2.45M 0.08% 208

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Avanza Fonder's WST Position: Q2 2026 in Review

Avanza Fonder reduced its West Pharmaceutical (WST) stake by 20% in Q2 2026, selling an estimated $463K and leaving 5,992 shares worth $2.15M. The position accounts for 0.05% of the portfolio, ranked #273.

Avanza Fonder first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.55M in Q4 2024. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Avanza Fonder held 5,992 shares of West Pharmaceutical worth $2.15M as of Q2 2026.
  • Avanza Fonder sold 1,516 West Pharmaceutical shares in Q2 2026, an estimated $463K.
  • West Pharmaceutical made up 0.05% of Avanza Fonder's portfolio in Q2 2026, its #273 holding.
  • Avanza Fonder first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's West Pharmaceutical position peaked at $2.55M in Q4 2024.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.